September 15, 2025 a 07:43 pm

BAX: Fundamental Ratio Analysis - Baxter International Inc.

Baxter International Inc. Stock Image

Baxter International Inc., headquartered in Deerfield, Illinois, provides a wide range of healthcare products worldwide. The company's broad portfolio includes dialysis therapies, infusion systems, and acute care products, serving hospitals and other medical facilities globally. Baxter's strategic partnerships and expansive sales network highlight its significant presence in the healthcare sector.

Fundamental Rating

The fundamental rating for Baxter International Inc. reflects a moderate level of financial health, with particular strengths and weaknesses outlined in the table below.

Category Score Visualization
Overall Score 2
Discounted Cash Flow 4
Return on Equity 1
Return on Assets 1
Debt to Equity 1
Price to Earnings 1
Price to Book 3

Historical Rating

The historical ratings provide insight into the trend of Baxter's financial performance. The stability of certain scores over time can be indicative of consistent financial management.

Date Overall Score DCF ROE ROA D/E P/E P/B
2025-09-15 2 4 1 1 1 1 3
N/A 0 4 1 1 1 1 3

Analyst Price Targets

Analysts have set various price targets for Baxter, reflecting differing opinions on future performance. The following table summarizes these targets.

High Low Median Consensus
36 24 30 30
Stock chart of Baxter International Inc.

Analyst Sentiment

Analyst sentiment indicates a predominantly cautious approach to Baxter's future performance, as demonstrated by the distribution of recommendations below.

Recommendation Number Visualization
Strong Buy 0
Buy 15
Hold 20
Sell 1
Strong Sell 0

Conclusion

Baxter International Inc. demonstrates a moderate stability in key financial metrics, though areas like Return on Equity and Return on Assets are weak. The analyst consensus leans toward holding the stock, reflecting uncertainty about significant short-term growth. The price targets indicate potential for modest gains. Overall, investing in Baxter may be suitable for those seeking long-term exposure to the healthcare sector, balancing potential rewards with inherent financial risks.